Safety and Efficacy of a Halobetasol/Tazarotene Fixed Combination in the Treatment of Moderate-To-Severe Plaque Psoriasis: Results of Two Phase 3 Randomized Controlled Trials
Journal of the American Academy of Dermatology - United States
doi 10.1016/j.jaad.2018.03.040
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 1, 2018
Authors
Publisher
Elsevier BV